The studies seem to be going well so far but there's no assurance final results will be good enough for a pharma to do a deal or buy us out.  Will they want to see more studies?  And if there is a deal or CVR, there's no assurance we will pocket any of the money.  ZEN may hold on to it to fund a Phase III and salaries.  Yes, the OTC price would go up but that would not be an easy exit for shareholders.